Medinice signs letter of intent with CorNav Corporation

September 18, 2025

Medinice S.A. announced the signing of a letter of intent with the U.S. company CorNav Corporation. The agreement concerns cooperation in research, development, and potential commercialization of medical technologies used in the treatment of ventricular tachycardia (VT).

As part of the collaboration, Medinice brings expertise from its MiniMax project (an innovative ablation catheter), while CorNav contributes its CardioScout navigation platform, which enables precise procedure guidance. The synergy of both solutions is expected to shorten procedure times and improve patient safety.

This is a strategic step that opens up opportunities for Medinice’s expansion into the U.S. market and strengthens the company’s position as an innovator in the medtech segment.